Diabetes Clinical Trials in Los Angeles

Showing 241-260 of 561 trials

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

NCT02489773

To confirm that Lucica ® Glycated Albumin-L is useful for the intermediate term (preceding 2-3 weeks) monitoring of glycemic control in patients with diabetes.

Diabetes

Asahi Kasei Therapeutics Corporation150 participantsStarted Jun 2015

Los Angeles, California, United States • Los Angeles, California, United States • Lexington, Kentucky, United States +5 more locations

COMPLETEDNA< 1 mile

Beta Cell Restoration Through Fat Mitigation

NCT01763346

Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.

PrediabetesType 2 DiabetesObesity

University of Southern California88 participantsStarted Jun 2013

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

NCT02648204

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S1,201 participantsStarted Jan 2016

Tuscumbia, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +206 more locations

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

Beta Cell Restoration Through Fat Mitigation

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Diabetes Trials in Other Cities

Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Evaluation of an Ascensia Diabetes Care ONYX PLUS Investigational Blood Glucose Monitoring System

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Other Conditions in Los Angeles